Scalper1 News
Big pharma Pfizer (PFE) agreed to buy specialty generics firm Hospira Thursday in a $17 billion deal, sending Hospira’s stock up 35% to a record high. Pfizer agreed to pay $90 a share in cash for Hospira (HSP), which sells generic injectables along with devices and systems to administer them. The firm said it should add 10 to 12 cents to EPS in the first year after the deal closes, which Pfizer expects to occur in the second half of this year. Scalper1 News
Scalper1 News